Register entry

Esperion Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
15
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
tablet, film coated2
RouteNDCs
oral2
Labeller name on the listingNDCs
esperion therapeutics, inc.2
Exclusivity

Patents and exclusivities

15
PatentProductCoversExpiry
7335799NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibesubstanceDec 2030
10912751NEXLIZETbempedoic acid; ezetimibeuseMar 2036
11744816NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibeuseMar 2036
11613511NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibesubstanceJun 2040
11760714NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibeproductJun 2040
11926584NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibeuseJun 2040
12398087NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibesubstance, productJun 2040
12404227NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibesubstanceJun 2040
ProductExclusivityUntil
NEXLETOLBEMPEDOIC ACIDI-943 New indicationMar 2027
NEXLIZETBEMPEDOIC ACID; EZETIMIBEI-943 New indicationMar 2027
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
NexletolBempedoic Acidtablet, film coated, oral72426-118NDA
NexlizetBempedoic Acid and Ezetimibetablet, film coated, oral72426-818NDA
Compare

Other companies listing bempedoic acid

Enquiry

Common questions

Is Esperion Therapeutics, Inc. FDA approved?
Esperion Therapeutics, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Esperion Therapeutics, Inc. make?
2 products are listed under Esperion Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.